Free Trial
TSE:CTX

Crescita Therapeutics (CTX) Stock Price, News & Analysis

Crescita Therapeutics logo
C$0.47 +0.01 (+1.08%)
As of 03:50 PM Eastern

About Crescita Therapeutics Stock (TSE:CTX)

Key Stats

Today's Range
C$0.47
C$0.47
50-Day Range
C$0.47
C$0.55
52-Week Range
C$0.45
C$0.69
Volume
18,594 shs
Average Volume
15,290 shs
Market Capitalization
C$8.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CTX Stock News Headlines

Crescita Therapeutics Inc. (CTX.TO) - Yahoo Finance
“All the land that you see I will give to you and your offspring forever…”
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Crescita Reports First Quarter 2025 Results
Crescita Reports First Quarter 2025 Results
Crescita Therapeutics Inc. (CRRTF)
Chordia Therapeutics Advances Cancer Drug Development
See More Headlines

CTX Stock Analysis - Frequently Asked Questions

Crescita Therapeutics' stock was trading at C$0.58 on January 1st, 2025. Since then, CTX shares have decreased by 19.0% and is now trading at C$0.47.

Shares of CTX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Crescita Therapeutics investors own include Baytex Energy (BTE), Argonaut Gold (AR), Birchcliff Energy (BIR), CBTX (CBTX), Crescent Point Energy (CPG), Enbridge (ENB) and IMV (IMV).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:CTX
CIK
N/A
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.61 million
Net Margins
-15.73%
Pretax Margin
N/A
Return on Equity
-15.60%
Return on Assets
-8.26%

Debt

Debt-to-Equity Ratio
5.77
Current Ratio
2.70
Quick Ratio
2.29

Sales & Book Value

Annual Sales
C$16.62 million
Price / Sales
0.52
Cash Flow
C$0.39 per share
Price / Cash Flow
1.20
Book Value
C$0.83 per share
Price / Book
0.56

Miscellaneous

Outstanding Shares
18,406,184
Free Float
N/A
Market Cap
C$8.65 million
Optionable
Not Optionable
Beta
1.69
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (TSE:CTX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners